Introduction:

Soft tissue injuries occur when there is trauma or overuse occurs to the muscles, tendons or the ligaments. The soft tissue injuries are mostly the result of sudden unexpected or uncontrolled movement like stepping awkwardly off a curb and rolling over your ankle. Further, the most common soft tissue injuries are ankle sprain, back strain, calf strain, golfers/Tennis elbow, and hamstring strain. The increasing incidence of injuries in the field of sports is attributed to the growth of soft tissue repair market. Further, the government funding for sports players for soft tissue repair also fosters the market. Moreover, increasing number of accidents is expected to boost the soft tissue repair market. For instance, in 2015, according to study conducted by US Department of Transportation the road accident incidents have been increased by 3.8%.Soft Tissue Market accounted for US$ 3.9 billion in 2020 and is estimated to be US$ 7.9 billion by 2030 and is anticipated to register a CAGR of 7.3%.

Growing number of patients suffering from sports-related injuries

Factors influencing the soft tissue market is growing of sport related injuries such as sprains, strains, contusions, bursitis and tendinitis. Growing awareness and impact of these injuries on athletes is expected to foster the market. According to the National Safety Council (NSC), in 2021 exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation. 

Further, increasing geriatric population overall the globe and their injuries is also expected to foster the global soft tissue market.

 

 

Soft tissue repair market is segmented on the basis of product type, application, end user and geography. On the basis of product type, the soft tissue repair has been segmented into Fixation Products (Interference Screws, suture anchors, and others) tissue patch (Biological mesh, synthetic mesh), and Others. On the basis of application, the soft tissue repair market is segmented into breast reconstruction, dental and dural repair, hernia repair, orthopedic repair, vaginal prolapse repair, skin repair, cardiovascular surgery, and others.  On the basis of end user, the lobal soft tissue repair has been segmented into hospital, clinics, ambulatory surgery centers, and others.

Regional Insights:

On the basis of region, the Soft Tissue Market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market overall the forecast period, due to significant healthcare expenditure, early availability of new technologies and increased research and development activities. Further, Asia Pacific is expected to exhibit highest CAGR overall the forecast period due to rising product launches, distribution agreements, acquisitions, alliances and presence of developing countries. 

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2029
Market representation	Revenue in USD Million & CAGR from 2020 – 2029
Market Segmentation	By Product type - Fixation Products (Interference Screws, suture anchors, and others) Tissue patch (Biological mesh, synthetic mesh), and Others By Application - Breast reconstruction, Dental and Dural repair, Hernia repair, Orthopedic repair, Vaginal prolapse repair, Skin repair, Cardiovascular surgery, and Others By End User - Hospital, Clinics, Ambulatory surgery centers, and Others By Region- North America, Latin America, Europe, Asia Pacific, Middle East, and Africa
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Soft Tissue Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the Soft Tissue Market includes Life Cell Corporation, Organogenesis, Smith And Nephew, Johnson And Johnson, Covidien, Arthrex Inc, Integra Life Sciences Corporation, Stryker Medical Corporation, Wright Medical Technology, C. R. Bard, De Puy Synthes, and American Medical Systems.

• Life Cell Corporation*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Organogensis
• Smith and Nephew
• Johnson and Johnson
• Covidien
• Arthrex Inc  
• Integra Life Sciences Corporation  
• Stryker Medical Corporation
• Wright Medical Technology
• C.R. Brad
• DePuy SYNTHES
• American Medical Systems

 “*” marked represents similar segmentation in other categories in the respective section

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Soft Tissue Strategies
     • Key Questions this Study will Answer

     • • By Product type ( Fixation Products (Interference Screws, suture anchors, and others) Tissue patch (Biological mesh, synthetic mesh), and Others)

       • By Application (Breast reconstruction, Dental and Dural repair, Hernia repair, Orthopedic repair, Vaginal prolapse repair, Skin repair, Cardiovascular surgery, and Others)

       • By End User (Hospital, Clinics, Ambulatory surgery centers, and Others)

       • By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) 

   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
   • Y-o-Y Growth Analysis (%), 2020 – 2030
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Soft Tissue Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies
• SWOT Analysis
• Life Cell Corporation, Organogenesis, Smith And Nephew, Johnson And Johnson, Covidien, Arthrex Inc, Integra Life Sciences Corporation, Stryker Medical Corporation, Wright Medical Technology, C. R. Bard, De Puy Synthes, and American Medical Systems.

The Last Word

• Future Impact
• About Us
• Contact